Vaccine development and new attempts of treatment for ragweed allergy

  • El-Qutob D
N/ACitations
Citations of this article
19Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Ragweeds are flowering plants in the genus Ambrosia in the aster family, Asteraceae. They are distributed in the tropical and subtropical regions of the New World, especially North America. Short ragweed is the most important weed. The ragweed flowering occurs late in the summer and the pollination period extends from the beginning of August to mid-October. Sensitization to ragweed pollen has risen in United States in the past decade and probably worldwide. The major allergenic compound in the pollen has been identified as Amb a 1. Ragweed allergies usually cause allergic rhinitis and asthma. Ragweed allergic patients may show signs of oral allergy syndrome caused by crossreactivity between ragweed allergens and food allergens. In the present article, an update about vaccine development and new knowledge for ragweed allergy is exhaustively revised.

Cite

CITATION STYLE

APA

El-Qutob, D. (2015). Vaccine development and new attempts of treatment for ragweed allergy. Therapeutic Advances in Vaccines, 3(2), 41–47. https://doi.org/10.1177/2051013614565354

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free